WallStreetZenWallStreetZen

NASDAQ: TVRD
Tvardi Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tvardi Therapeutics revenue was $7.14M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.5M, down 43.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TVRD annual revenue was $7.1M, with -66% growth year-over-year.

TVRD past revenue growth

How has TVRD's revenue growth performed historically?

Company
-65.96%
Industry
497.69%
Market
20.68%
TVRD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TVRD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TVRD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TVRD revenue history

Current Revenue
$7.1M
Current Earnings
-$70.9M
Current Profit Margin
-993%

Be the first to know when TVRD announces revenue.

TVRD Revenue History By Year

TVRD Yearly RevenueTVRD RevenueTVRD ChangeTVRD Revenue Growth
2024-12-31$7.14M-$13.83M-65.96%
2023-12-31$20.97M-$20.90M-49.92%
2022-12-31$41.87M$18.84M+81.81%
2021-12-31$23.03M-$112.05M-82.95%
2020-12-31$135.08M$115.20M+579.28%
2019-12-31$19.89M$6.42M+47.64%
2018-12-31$13.47M$12.56M+1,378.49%
2017-12-31$911.00k$825.00k+959.30%
2016-12-31$86.00k-$3.72M-97.74%
2015-12-31$3.80M$626.00k+19.70%
2014-12-31$3.18M-$8.79M-73.45%
2013-12-31$11.96M$10.77M+905.38%
2012-12-31$1.19MN/AN/A
2011-12-31$0.00N/AN/A

1 of 1

Tvardi Therapeutics Revenue FAQ

What was TVRD's revenue last quarter?

On Invalid Date, Tvardi Therapeutics (NASDAQ: TVRD) reported Q4 2024 revenue of $1.46 million up 51.56% year over year. In the same quarter last year, Tvardi Therapeutics's revenue was $3.00 million.

What was Tvardi Therapeutics's revenue in 2024?

Tvardi Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $7.14 million, a 65.96% decrease year over year.

How much does Tvardi Therapeutics make in a day?

Based on Tvardi Therapeutics annual revenue for the past five years, TVRD makes an average of $124,976.44 per day.

What was Tvardi Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Tvardi Therapeutics's revenue has grown -65.96% year over year. This is 563.66 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Tvardi Therapeutics's revenue in the past year totaled $7.14 million.

How much does Tvardi Therapeutics make in a year?

Tvardi Therapeutics's revenue by year for the past five years is:
  • Tvardi Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $7.14 million, a 65.96% decrease year over year.
  • Tvardi Therapeutics's annual revenue for Dec 31, 2023 was $20.97 million, a 49.92% decrease from 2022.
  • Tvardi Therapeutics's annual revenue for 2022 was $41.87 million, a 81.81% increase from 2021.
  • Tvardi Therapeutics's annual revenue for 2021 was $23.03 million, a 82.95% decrease from 2020.
  • Tvardi Therapeutics's annual revenue for 2020 was $135.08 million, a 579.28% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.